Main station|Member Center|Save the desktop|Mobile browsing
Ordinary Member

Ruikang Pharmaceutical Company

All over the country

sell
  • There is no classification
contact
  • Contact:刘双
  • Phone:13522229957
search
 
link
  • There is no link yet
home > sell > Erlotinib price in India for sale in Zhengzhou 13522229957 Tarceva price in India
Erlotinib price in India for sale in Zhengzhou 13522229957 Tarceva price in India
products: Views:3Erlotinib price in India for sale in Zhengzhou 13522229957 Tarceva price in India 
price: 3000.00元/盒
MOQ: 1 盒
Total supply: 10000 盒
Delivery date: Shipped within 1 days from the date of payment by the buyer
Valid until: Long-term validity
Last updated: 2016-11-06 17:35
 
Details

[Our company promises: honesty, genuine products at reasonable prices, selling conscientious medicines, cash on delivery]
Beijing Ruikang Medicine
Contact person: Liu Shuang (Ms.)
Contact number QQ
Tarceva erlotinib price/box in India
[Trade name] Tarceva
[English trade name]
[Common name] Erlotinib tablets
/> [English common name] Hb
[Mechanism of action] The main mechanism of action of r is to inhibit the intracellular phosphorylation of epidermal growth factor (R) tyrosine kinase
[Indications] Erlotinib can Trial for third-line treatment of locally advanced or metastatic non-small cell lung cancer that has failed two or more chemotherapy regimens.
【Pharmacokinetics】% absorbed after oral administration, half-life is about hours, and is mainly eliminated by metabolism. The bioavailability of oral rm is about %, and peak plasma concentration is reached after several hours.
The pharmacokinetic analysis of the patient treated with r alone showed that it takes days to reach stable blood concentration. The patient's age, weight, and gender have no significant relationship with the clearance rate of the drug. Smoking can increase the clearance rate of the drug. %.
【Contraindications】Contraindicated for those allergic to this product and its ingredients.
[Precautions] This product must be used under the guidance of doctors who have experience in using such drugs, and can only be used in national drug clinical trial bases or tertiary A hospitals.
[Usage and Dosage] The recommended dose of erlotinib monotherapy for non-small cell lung cancer is m/day, which should be taken at least one hour before or one hour after eating.
[Adverse reactions] The most common adverse reactions are rash and diarrhea. The incidence rates of rash and diarrhea are % and % respectively. The median appearance time of rash is days and the median appearance time of diarrhea is days.
[Specification packaging] m/tablet/box (one month's dosage)
[Validity period] months
[Storage] Store at ℃, and it is also acceptable between ℃ and ℃.
Request for quotation
A total of0articles  Related Comments: